Marion M. Brands

796 total citations
34 papers, 438 citations indexed

About

Marion M. Brands is a scholar working on Physiology, Molecular Biology and Rheumatology. According to data from OpenAlex, Marion M. Brands has authored 34 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 14 papers in Molecular Biology and 6 papers in Rheumatology. Recurrent topics in Marion M. Brands's work include Lysosomal Storage Disorders Research (17 papers), Cellular transport and secretion (5 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Marion M. Brands is often cited by papers focused on Lysosomal Storage Disorders Research (17 papers), Cellular transport and secretion (5 papers) and Genetics and Neurodevelopmental Disorders (5 papers). Marion M. Brands collaborates with scholars based in Netherlands, Canada and United States. Marion M. Brands's co-authors include Ans T. van der Ploeg, Esmée Oussoren, George J. G. Ruijter, Arnold Reuser, Wim C.J. Hop, Judith M. Deckers‐Kocken, Iris Plug, Willem A. Helbing, Ingrid M.E. Frohn-Mulder and Frits A. Wijburg and has published in prestigious journals such as Neurology, Progress in Retinal and Eye Research and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Marion M. Brands

31 papers receiving 431 citations

Peers

Countries citing papers authored by Marion M. Brands

Since Specialization

Citations

This map shows the geographic impact of Marion M. Brands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion M. Brands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion M. Brands more than expected).

Fields of papers citing papers by Marion M. Brands

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion M. Brands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion M. Brands. The network helps show where Marion M. Brands may publish in the future.

Co-authorship network of co-authors of Marion M. Brands

This figure shows the co-authorship network connecting the top 25 collaborators of Marion M. Brands. A scholar is included among the top collaborators of Marion M. Brands based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion M. Brands. Marion M. Brands is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected? 2025 ·Acta Ophthalmologica ·Mark J. Buijs, (unknown), Marion M. Brands, Anneloor L.M.A. ten Asbroek, Camiel J.F. Boon, Roselie M.H. Diederen, (unknown), Margreet A. E. M. Wagenmakers, Hans R. Waterham, Ronald J. A. Wanders, Riekelt H. Houtkooper, Clara D. van Karnebeek, Arthur A. Bergen	0
2	Effectiveness of Pyridoxal‐5′‐Phosphate in PNPO Deficiency: A Systematic Review 2025 ·Journal of Inherited Metabolic Disease ·(unknown), Laura van Dussen, (unknown), Marion M. Brands, Bregje Jaeger, Peter T. Clayton, Carla E. M. Hollak, Annet M. Bosch	0
3	Novel Insights Into Gyrate Atrophy of the Choroid and Retina (GACR): A Cohort Study 2025 ·Journal of Inherited Metabolic Disease ·(unknown), (unknown), Camiel J. F. Boon, Martijn C.G.J. Brouwers, Roselie M.H. Diederen, (unknown), Peter M. van Hasselt, Bregje Jaeger, (unknown), Alexander J. Rennings, Francjan J. van Spronsen, (unknown), Margreet A. E. M. Wagenmakers, Julie De Zaeytijd, Bart P. Leroy, Andreas Schulze, Clara D. van Karnebeek, Marion M. Brands	1
4	Breaking the chains of lipoprotein lipase deficiency: A pediatric perspective on the efficacy and safety of Volanesorsen 2024 ·Molecular Genetics and Metabolism ·(unknown), Marion M. Brands, Ilse J.M. Nijhuis, (unknown), (unknown), G.H. Hofsteenge, Bart G.P. Koot, (unknown), Laura A. Tseng, Erik S.G. Stroes, Peter M. van de Ven, Albert Wiegman, Clara van Karnebeek	2
5	Clinical and preclinical insights into high-dose ambroxol therapy for Gaucher disease type 2 and 3: A comprehensive systematic review 2024 ·Molecular Genetics and Metabolism ·(unknown), (unknown), Eleonora L. Swart, Hennie Bikker, Carla E. M. Hollak, Marion M. Brands	4
6	A mini-review on the international gyrate atrophy symposium 2023: More than meets the eye. Focus on outstanding research questions 2024 ·Molecular Genetics and Metabolism ·Marion M. Brands, (unknown), K. Ravi Acharya, Arthur A. Bergen, Nicola Brunetti‐Pierri, Mark J. Buijs, Barbara Cellini, (unknown), Mandeep Singh, Andreas Schulze, (unknown), David Valle, Ronald J. A. Wanders, Kirmo Wartiovaara, Clara van Karnebeek	1
7	Natural disease course of chronic visceral acid sphingomyelinase deficiency in adults: A first step toward treatment criteria 2024 ·Journal of Inherited Metabolic Disease ·(unknown), Laura van Dussen, Marion M. Brands, Frédéric M. Vaz, Johannes M. F. G. Aerts, André B. P. Kuilenburg, Barbara Sjouke, Carla E. M. Hollak	2
8	Navigating the outcome maze: a scoping review of outcomes and instruments in clinical trials in genetic neurodevelopmental disorders and intellectual disability 2024 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Marion M. Brands, Lotte Haverman, Caroline B. Terwee, Carlo Schuengel, Joost G. Daams, David Hessl, Frits A. Wijburg, Erik Boot, Agnies M. van Eeghen	5
9	Platelet proteomic profiling in sitosterolemia suggests thrombocytopenia is driven by lipid disorder and not platelet aberrations 2024 ·Blood Advances ·(unknown), Anton T. J. Tool, Karin van Leeuwen, Floris P. J. van Alphen, Marion M. Brands, Monique H. Suijker, Alexander B. Meijer, Arie J. Hoogendijk, Taco W. Kuijpers	1
10	Different diseases, different needs: Patient preferences for gene therapy in lysosomal storage disorders, a probabilistic threshold technique survey 2024 ·Orphanet Journal of Rare Diseases ·(unknown), (unknown), Jorien Veldwijk, Marion M. Brands, (unknown), (unknown), Mirjam Langeveld, Carla E. M. Hollak, Barbara Sjouke	1
11	Syndromic retinitis pigmentosa 2024 ·Progress in Retinal and Eye Research ·(unknown), (unknown), (unknown), Astrid S. Plomp, Ronald J. A. Wanders, Carel B. Hoyng, Mary J. van Schooneveld, Nicoline E. Schalij‐Delfos, Marion M. Brands, Bart P. Leroy, Clara D. van Karnebeek, Arthur A. Bergen, Maria M. van Genderen, Camiel J.F. Boon	7
12	A cohort study of 19 patients with gyrate atrophy of the choroid and retina (GACR) 2024 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·(unknown), (unknown), Marion M. Brands, Clara D. van Karnebeek, Arthur A. Bergen, L. Ingeborgh van den Born, Riekelt H. Houtkooper, Margreet A. E. M. Wagenmakers, Julie De Zaeytijd, Bart P. Leroy, Camiel J. F. Boon, Roselie M.H. Diederen	4
13	Oral sialic acid supplementation inNANS‐CDG: Results of a single center, open‐label, observational pilot study 2023 ·Journal of Inherited Metabolic Disease ·(unknown), Marion M. Brands, Lonneke de Boer, Charlotte A. Haaxma, Anna Lengyel, (unknown), (unknown), (unknown), Willemijn M. Klein, Karlien L. M. Coene, Dirk J. Lefeber, Clara van Karnebeek	1
14	Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiency 2023 ·Molecular Genetics and Metabolism ·(unknown), (unknown), Barbara Sjouke, Laura Van de Vliet, Marion M. Brands, Carla E. M. Hollak, Johannes M. F. G. Aerts	4
15	Evidence for effect of l-serine, a novel therapy for GRIN2B-related neurodevelopmental disorder 2023 ·Molecular Genetics and Metabolism ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mireia Olivella, Xavier Altafaj, Marion M. Brands, Bart Jacobs, Clara D. van Karnebeek	10
16	A vitamin a day keeps the doctor away: The need for high quality pyridoxal-5′-phosphate 2022 ·European Journal of Paediatric Neurology ·(unknown), Marion M. Brands, Liesbeth S. Smit, (unknown), Carla E. M. Hollak, Clara D. van Karnebeek	6
17	Patients’ view on gene therapy development for lysosomal storage disorders: a qualitative study 2022 ·Orphanet Journal of Rare Diseases ·(unknown), Cathrien Beishuizen, (unknown), Tessa van Middelaar, Marion M. Brands, (unknown), (unknown), Mirjam Langeveld, Carla E. M. Hollak, Barbara Sjouke	2
18	Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression 2021 ·Molecular Genetics and Metabolism ·(unknown), (unknown), Alexander Hirsch, Carla E. M. Hollak, Frits A. Wijburg, Marion M. Brands, Camilla Tøndel, André B. P. Kuilenburg, Mirjam Langeveld	18
19	Macrophage involvement in mitral valve pathology in mucopolysaccharidosis type VI (Maroteaux–lamy syndrome) 2013 ·American Journal of Medical Genetics Part A ·Marion M. Brands, (unknown), Ronald R. de Krijger, Ad J.J.C. Bogers, Arnold Reuser, Ans van der Ploeg, Willem A. Helbing	5
20	Bone, joint and tooth development in mucopolysaccharidoses: Relevance to therapeutic options 2011 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Esmée Oussoren, Marion M. Brands, George J. G. Ruijter, Ans T. van der Ploeg, Arnold Reuser	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact